1. Home
  2. WEST vs ADCT Comparison

WEST vs ADCT Comparison

Compare WEST & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westrock Coffee Company

WEST

Westrock Coffee Company

N/A

Current Price

$3.85

Market Cap

428.0M

ML Signal

N/A

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

N/A

Current Price

$4.15

Market Cap

484.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WEST
ADCT
Founded
2009
2011
Country
United States
Switzerland
Employees
1408
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.0M
484.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WEST
ADCT
Price
$3.85
$4.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$9.00
$7.50
AVG Volume (30 Days)
239.5K
801.2K
Earning Date
01-01-0001
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.90
EPS
N/A
N/A
Revenue
N/A
$70,837,000.00
Revenue This Year
$39.88
$14.96
Revenue Next Year
$14.87
$1.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.84
52 Week Low
$3.59
$1.05
52 Week High
$7.92
$4.80

Technical Indicators

Market Signals
Indicator
WEST
ADCT
Relative Strength Index (RSI) 25.05 54.53
Support Level $3.60 $3.93
Resistance Level $4.67 $4.71
Average True Range (ATR) 0.20 0.24
MACD -0.13 -0.02
Stochastic Oscillator 13.70 33.56

Price Performance

Historical Comparison
WEST
ADCT

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: